Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of colloids on hemostasis in paediatric anaesthesia
2004-001610-14Phase 4Completed
- Sponsor
- Univ. hospital, Dpt. of anaesthesia
- Start
- Feb 2005
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of Volulyte, succinylated gelatin and albumin (human) in abnormal hemostasis and Intraoperative blood loss (EBL) (3 arms), sponsored by Univ. hospital, Dpt. of anaesthesia. Primary endpoint: Change in hemostasis parameters after colloid infusion within each group. Started Feb 2005; status: completed.
02
Drugs
Volulytesuccinylated gelatinalbumin (human)
03
Conditions
abnormal hemostasisIntraoperative blood loss (EBL)
Beyond the preview
Go deeper on 2004-001610-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001610-14.